Right Offering Information

Dear Actinium Investor,

As you know we are currently conducting a rights offering for up to $25 million in gross proceeds. We’ve received several questions about our rights offering and wanted to direct you to information that may be helpful to you.  Below you will find the contact information for many of the leading brokerage firms. Your respective brokerage firm can help you with any questions you may have. 

TD Ameritrade: 800-669-3900

Trade Station: 800-808-9336

Fidelity: 800-631-1903

Charles Schwab: 800-435-9050; 800-435-4000

First Trade: 800-869-8800

Interactive Brokers: 877-442-2757 (8 AM to 8 PM)

Pershing: 800-445-4467

UBS: 800-354-9103

Merrill Lynch: 800-637-7455

Citibank: 877-357-3399

APEX Clearing Corp: 214-765-1100

BROWN BROS Harriman: 212-483-1818

Vanguard Brokerage Services: 800-991-8327

BNY Mellon Investor Access: 855-284-9065

WellsTrade (Wells Fargo): 877-573-7997; 866-245-3452; 800-872-3377

Please note, that your broker, financial advisor, dealer, bank or other nominee may establish a deadline before March 2, 2018,  

In addition, you can contact Broadridge Corporate Issuer Solutions, Inc., the information agent for the rights offering:

(855) 793-5068 (toll free) 

Link to Rights Offering Prospectus: https://www.sec.gov/Archives/edgar/data/1388320/000121390018002272/0001213900-18-002272-index.htm

Link to Rights Offering Announcement: https://ir.actiniumpharma.com/press-releases/detail/272/actinium-pharmaceuticals-reiterates-previously-announced